Related references
Note: Only part of the references are listed.Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103
Kathryn J. Ruddy et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma
Julia Meissner et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Risk of Premature Menopause After Treatment for Hodgkin's Lymphoma
Anthony J. Swerdlow et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Age at menopause and its influencing factors in a cohort of survivors of childhood cancer: earlier but rarely premature
Cecile Thomas-Teinturier et al.
HUMAN REPRODUCTION (2013)
Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials
Karolin Behringer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Anti-Mullerian Hormone and Antral Follicle Count Reveal a Late Impairment of Ovarian Reserve in Patients Undergoing Low-Gonadotoxic Regimens for Hematological Malignancies
Rossana Di Paola et al.
ONCOLOGIST (2013)
Ovarian Function in Female Survivors of Childhood Malignancies
Amr H. El-Shalakany et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2013)
Accelerating Ovarian Age: Cancer Treatment in the Premenopausal Woman
Joseph Letourneau et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2013)
How do chemotherapeutic agents damage the ovary?
S. Morgan et al.
HUMAN REPRODUCTION UPDATE (2012)
Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study
Marleen A. E. van der Kaaij et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Measuring anti-Mullerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?
R. A. Anderson et al.
MATURITAS (2012)
Gonadal function and parenthood 20 years after treatment for childhood lymphoma: A cross-sectional study
Hanne Hamre et al.
PEDIATRIC BLOOD & CANCER (2012)
Age-related distribution of basal serum AMH level in women of reproductive age and a presumably healthy cohort
Omar Shebl et al.
FERTILITY AND STERILITY (2011)
Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results
Christine Decanter et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone
S. Lie Fong et al.
HUMAN REPRODUCTION (2009)
Ovarian Failure and Reproductive Outcomes After Childhood Cancer Treatment: Results From the Childhood Cancer Survivor Study
Daniel M. Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies
S. Lie Fong et al.
HUMAN REPRODUCTION (2008)
Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition
MaryFran R. Sowers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Treatment-related risk factors for premature menopause following Hodgkin lymphoma
Marie L. De Bruin et al.
BLOOD (2008)
Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function
Ozgur Oktem et al.
CANCER (2007)
Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-term results from International Breast Cancer Study Group Trials V and VI
Ann Partridge et al.
EUROPEAN JOURNAL OF CANCER (2007)
Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
U. K. H. Haukvik et al.
ANNALS OF ONCOLOGY (2006)
Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study
Charles A. Sklar et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
Fertility status among women treated for aggressive non-Hodgkin's lymphoma
A Elis et al.
LEUKEMIA & LYMPHOMA (2006)
Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life
P Gupta et al.
CLIMACTERIC (2006)
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas:: results of the NHL-B1 trial of the DSHNHL
M Pfreundschuh et al.
BLOOD (2004)
Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound
LE Bath et al.
HUMAN REPRODUCTION (2003)
Share Paper
